Feedback
Settings

Settings

Goto Application

1. WO2016168281 - EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER AND DIABETES

PermaLink
Publication Number WO/2016/168281
Publication Date 20.10.2016
International Application No. PCT/US2016/027262
International Filing Date 13.04.2016
IPC
C07D 487/08 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
487Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/-C07D477/183
02in which the condensed system contains two hetero rings
08Bridged systems
C07D 493/08 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
493Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
02in which the condensed system contains two hetero rings
08Bridged systems
C07D 495/08 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
495Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
02in which the condensed system contains two hetero rings
08Bridged systems
A61K 31/35 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
A61P 35/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
CPC
A61P 3/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
A61P 35/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
02specific for leukemia
C07D 487/08
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
487Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
02in which the condensed system contains two hetero rings
08Bridged systems
C07D 493/08
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
493Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
02in which the condensed system contains two hetero rings
08Bridged systems
C07D 495/08
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
495Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
02in which the condensed system contains two hetero rings
08Bridged systems
Applicants
  • THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES [US]/[US]
  • FUNDACIO INSTITUT CATALA D'INVESTIGACIO QUIMICA [ES]/[ES]
  • UNIVERSITAT ROVIRA I VIRGILI [ES]/[ES]
Inventors
  • BEUTLER, John A.
  • ECHAVARREN, Antonio M.
  • LOPEZ, Laura
  • BRAVO, Fernando
  • RIESGO, Lorena
  • RANSOM, Tanya Tannaquil
Agents
  • PILLAI, Xavier
Priority Data
62/146,80513.04.2015US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) EPOXYAZULENE DERIVATIVES USEFUL FOR TREATING CANCER AND DIABETES
(FR) DÉRIVÉS D'ÉPOXYAZULÈNE UTILES POUR TRAITER LE CANCER ET LE DIABÈTE
front page image
Abstract
(EN)
Disclosed is a compound of formula (I) in which R1-R5 and X1 are as described herein. Also provided are methods of using a compound of formula (I), including a method of treating cancer and a method of treating diabetes.
(FR)
L'invention concerne un composé de formule (I) dans laquelle R1-R5 et X1 sont tels que décrits ici. L'invention concerne également des procédés d'utilisation d'un composé de formule (I), comprenant un procédé de traitement du cancer et un procédé de traitement du diabète.
Also published as
AU2016247920
EP3283489
US20180127433
JP2018514526
DK3283489
ES2754789
CA2982564
Latest bibliographic data on file with the International Bureau
# -